Salvage treatment of AOSD-associated macrophage activation syndrome with bariticinib following conventional immunosuppressive therapy. Xu Y, Yin Y, Li W, Zhou J, et al. Clin Rheumatol 2025;44:1705-1712.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Xu Y, Yin Y, Li W, Zhou J, et al. Salvage treatment of AOSD-associated macrophage activation syndrome with bariticinib following conventional immunosuppressive therapy. Clin Rheumatol 2025;44:1705-1712.
PMID: 39939513